| HIV-1 antiretroviral drug therapy EJ Arts, DJ Hazuda Cold Spring Harbor perspectives in medicine 2 (4), a007161, 2012 | 1382 | 2012 |
| Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease DM Tebit, EJ Arts The Lancet infectious diseases 11 (1), 45-56, 2011 | 358 | 2011 |
| HLA-B57/B* 5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T … T Miura, MA Brockman, A Schneidewind, M Lobritz, F Pereyra, A Rathod, ... Journal of virology 83 (6), 2743-2755, 2009 | 344 | 2009 |
| A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression ME Quiñones-Mateu, SC Ball, AJ Marozsan, VS Torre, JL Albright, ... Journal of virology 74 (19), 9222-9233, 2000 | 310 | 2000 |
| The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates KK Ariën, A Abraha, ME Quinones-Mateu, L Kestens, G Vanham, EJ Arts Journal of virology 79 (14), 8979-8990, 2005 | 295 | 2005 |
| Is HIV-1 evolving to a less virulent form in humans? KK Ariën, G Vanham, EJ Arts Nature Reviews Microbiology 5 (2), 141-151, 2007 | 284 | 2007 |
| Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C SC Ball, A Abraha, KR Collins, AJ Marozsan, H Baird, ... Journal of virology 77 (2), 1021-1038, 2003 | 259 | 2003 |
| Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression RM Troyer, KR Collins, A Abraha, E Fraundorf, DM Moore, RW Krizan, ... Journal of virology 79 (14), 9006-9018, 2005 | 245 | 2005 |
| Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response RM Troyer, J McNevin, Y Liu, SC Zhang, RW Krizan, A Abraha, DM Tebit, ... PLoS pathogens 5 (4), e1000365, 2009 | 239 | 2009 |
| Impact of tuberculosis on HIV-1 replication, diversity, and disease progression KR Collins, ME Quiñones-Mateu, Z Toossi, EJ Arts Aids Rev 4 (3), 165-76, 2002 | 175 | 2002 |
| Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription EJ Arts, MA Wainberg Antimicrobial agents and chemotherapy 40 (3), 527-540, 1996 | 175 | 1996 |
| Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA (Lys3) in vitro: studies of viral … X Li, Y Quan, EJ Arts, Z Li, BD Preston, H De Rocquigny, BP Roques, ... Journal of Virology 70 (8), 4996-5004, 1996 | 166 | 1996 |
| Fitness of drug resistant HIV-1: methodology and clinical implications ME Quiñones-Mateu, EJ Arts Drug Resistance Updates 5 (6), 224-233, 2002 | 148 | 2002 |
| HIV diversity, recombination and disease progression: how does fitness “fit” into the puzzle DM Tebit, I Nankya, EJ Arts, Y Gao Aids Rev 9 (2), 75-87, 2007 | 146 | 2007 |
| HIV-1 fitness: implications for drug resistance, disease progression, and global epidemic evolution ME Quiñones-Mateu, EJ Arts HIV sequence compendium 2001, 134-170, 2001 | 146 | 2001 |
| Comparison of deoxyoligonucleotide and tRNA (Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction. EJ Arts, X Li, Z Gu, L Kleiman, MA Parniak, MA Wainberg Journal of Biological Chemistry 269 (20), 14672-14680, 1994 | 145 | 1994 |
| Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication X Li, J Mak, EJ Arts, Z Gu, L Kleiman, MA Wainberg, MA Parniak Journal of virology 68 (10), 6198-6206, 1994 | 143 | 1994 |
| Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates AJ Marozsan, E Fraundorf, A Abraha, H Baird, D Moore, R Troyer, ... Journal of virology 78 (20), 11130-11141, 2004 | 137 | 2004 |
| Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry AJ Marozsan, DM Moore, MA Lobritz, E Fraundorf, A Abraha, JD Reeves, ... Journal of virology 79 (11), 7121-7134, 2005 | 129 | 2005 |
| Elite suppressor–derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics KG Lassen, MA Lobritz, JR Bailey, S Johnston, S Nguyen, B Lee, T Chou, ... PLoS pathogens 5 (4), e1000377, 2009 | 120 | 2009 |
